BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1732534)

  • 1. Total synthesis of uracil analogues of sinefungin.
    Barton DH; Géro SD; Lawrence F; Robert-Gero M; Quiclet-Sire B; Samadi M
    J Med Chem; 1992 Jan; 35(1):63-7. PubMed ID: 1732534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activity of sinefungin analogues.
    Blanchard P; Dodic N; Fourrey JL; Lawrence F; Mouna AM; Robert-Gero M
    J Med Chem; 1991 Sep; 34(9):2798-803. PubMed ID: 1895298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania donovani: antagonistic effect of S-adenosyl methionine on ultrastructural changes and growth inhibition induced by sinefungin.
    Phelouzat MA; Lawrence F; Moulay L; Borot C; Schaeverbeke J; Schaeverbeke M; Robert-Gero M
    Exp Parasitol; 1992 Mar; 74(2):177-87. PubMed ID: 1740179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmania donovani: enhanced expression of soluble acid phosphatase in the presence of sinefungin, an antiparasitic agent.
    Moulay L; Robert-Gero M
    Exp Parasitol; 1995 Feb; 80(1):8-14. PubMed ID: 7821414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sinefungin and taxol effects on cell cycle and cytoskeleton of Leishmania donovani promastigotes.
    Moulay L; Robert-Gero M; Brown S; Gendron MC; Tournier F
    Exp Cell Res; 1996 Aug; 226(2):283-91. PubMed ID: 8806432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of 2-arylbenzimidazoles targeting Leishmania donovani.
    Keurulainen L; Siiskonen A; Nasereddin A; Kopelyanskiy D; Sacerdoti-Sierra N; Leino TO; Tammela P; Yli-Kauhaluoma J; Jaffe CL; Kiuru P
    Bioorg Med Chem Lett; 2015 May; 25(9):1933-7. PubMed ID: 25827525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of 2-pyridyl pyrimidines with in vitro antiplasmodial and antileishmanial activity.
    Musonda CC; Whitlock GA; Witty MJ; Brun R; Kaiser M
    Bioorg Med Chem Lett; 2009 Jan; 19(2):401-5. PubMed ID: 19091562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sinefungin on growth and sterol composition of Leishmania promastigotes.
    Haughan PA; Chance ML; Goad LJ
    Exp Parasitol; 1993 Sep; 77(2):147-54. PubMed ID: 8375483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of macromolecular methylations in promastigotes of Leishmania donovani and impact of sinefungin.
    Lawrence F; Robert-Gero M
    J Eukaryot Microbiol; 1993; 40(5):581-9. PubMed ID: 8401471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of sinefungin-resistant Leishmania donovani promastigotes.
    Phelouzat MA; Lawrence F; Robert-Gero M
    Parasitol Res; 1993; 79(8):683-9. PubMed ID: 8295906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antileishmanial ferrocenylquinoline derivatives: Synthesis and biological evaluation against Leishmania donovani.
    Yousuf M; Mukherjee D; Dey S; Pal C; Adhikari S
    Eur J Med Chem; 2016 Nov; 124():468-479. PubMed ID: 27598235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of novel substituted quinazoline derivatives as antileishmanial agents.
    Agarwal KC; Sharma V; Shakya N; Gupta S
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5474-7. PubMed ID: 19692240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimalarial and Antileishmanial Activities of Phytophenolics and Their Synthetic Analogues.
    Morimoto M; Cantrell CL; Khan S; Tekwani BL; Duke SO
    Chem Biodivers; 2017 Dec; 14(12):. PubMed ID: 28990331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antileishmanial activity of C7- and C12-functionalized dehydroabietylamine derivatives.
    Dea-Ayuela MA; Bilbao-Ramos P; Bolás-Fernández F; González-Cardenete MA
    Eur J Med Chem; 2016 Oct; 121():445-450. PubMed ID: 27318121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antiprotozoal activity of some new synthetic substituted quinoxalines.
    Hui X; Desrivot J; Bories C; Loiseau PM; Franck X; Hocquemiller R; Figadère B
    Bioorg Med Chem Lett; 2006 Feb; 16(4):815-20. PubMed ID: 16309903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular target of the antileishmanial action of sinefungin.
    Nolan LL
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1542-8. PubMed ID: 3124733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of sinefungin susceptibility and drug-affinity for protein carboxymethyltransferase activity in American Leishmania species.
    Avila JL; Avila A
    Mol Biochem Parasitol; 1987 Nov; 26(1-2):69-75. PubMed ID: 3431568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syntheses of new substituted triazino tetrahydroisoquinolines and beta-carbolines as novel antileishmanial agents.
    Kumar A; Katiyar SB; Gupta S; Chauhan PM
    Eur J Med Chem; 2006 Jan; 41(1):106-13. PubMed ID: 16356594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antileishmanial effect of free and encapsulated sinefungin against Leishmania donovani infections in BALB/c mice.
    Neal RA; Iwobi MV; Robert-Gero M
    C R Acad Sci III; 1989; 308(18):485-8. PubMed ID: 2508995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro antileishmanial activity of 5-substituted-2'-deoxyuridine derivatives.
    Peyron C; Benhida R; Bories C; Loiseau PM
    Bioorg Chem; 2005 Dec; 33(6):439-47. PubMed ID: 16168460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.